(Q44514354)

3 December 2017

title

Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis (English)

1 reference

3 December 2017

1

1 reference

3 December 2017

5

1 reference

3 December 2017

Marina Saresella

3

0 references

Daria Lucia Trabattoni

object named as

Daria Trabattoni

series ordinal

2

0 references

author name string

Flavio Fantini

series ordinal

4

1 reference

3 December 2017

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

108

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

21-28

1 reference

Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Cellular infiltrates in scleroderma skin

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Immunologic aspects of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Cytokine production and serum levels in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Pathogenesis of scleroderma. Collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Immunopathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leucocytes from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Elevated serum level of interleukin-10 in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

1 reference

7 January 2021

Abnormalities of T lymphocyte subsets in systemic sclerosis demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Down-regulation of CD28 expression by TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Differential T cell costimulatory requirements in CD28-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Fas ligand mediates activation-induced cell death in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Fas ligand in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2803%2900062-7

7 January 2021

10.1016/S1521-6616(03)00062-7

Identifiers

DOI

1 reference

3 December 2017

1 reference